NCT02736162View on ClinicalTrials.gov

Study to Investigate Dosage, Efficacy, and Safety of Perampanel Given as Monotherapy in Patients With Epilepsy

CompletedOBSERVATIONAL
Enrollment

61

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

June 30, 2016

Study Completion Date

July 31, 2016

Conditions
EpilepsyPartial-Onset SeizuresPrimary Generalized Tonic-Clonic Seizures
Interventions
OTHER

No treatment (intervention) was administered

All Listed Sponsors
lead

Eisai Inc.

INDUSTRY

NCT02736162 - Study to Investigate Dosage, Efficacy, and Safety of Perampanel Given as Monotherapy in Patients With Epilepsy | Biotech Hunter | Biotech Hunter